Propolis is a special resin and wax material collected from the leaves and shells of trees, buds and shoots of plants by honey bees (Apis mellifera L.). In recent years, many researchers have studied the chemical composition, biological activity and pharmacological properties of propolis. The colour, odour and pharmacological properties of the propolis composition also vary as the composition changes depending on the plant, region, season and bee colony. Flavonoids, aromatic acids, phenolic acids and esters are the main compounds responsible for the biological activity of propolis. A number of studies have been conducted on the use of propolis or its active ingredients in the treatment of cancer. It has been observed that the use of propolis did not cause side effects according to in-vitro and in-vivo studies. Propolis should be extracted with different compounds for use in biological assays. The most commonly used compounds for extraction are ethanol, methanol, oil and water. A number of studies have been carried out showing the antitumor effect of propolis in cell culture and animal tests. The search for new drugs derived from natural products, which may function as chemotherapeutic agents and have low side effects, has increased in recent years. Combination with antioxidant therapy may improve the side effects of chemotherapy on leukocytes, liver and kidney, thus increasing the effect of chemotherapy with dose increase.
In this study, rhubarb plant, which is known to have functional properties, was added to gluten-free biscuit formulations and the effects of rhubarb were examined on the physical and antioxidant properties of biscuits. From the examination, it was observed that the spread ratio of the biscuits varied between 51.70 and 63.80. Also, the spread ratios of the biscuits decreased as the rhubarb and gum levels increased. Firmness values of the gluten-free biscuits were 29.71-54.02 N. The increase in gum levels of biscuit formulas that did not contain rhubarb led to an increase in the firmness values. Total phenolic content (TPC) of the biscuits varied between 2.00 and 3.18 ?g GAE/g. The lowest TPC value was determined in the biscuit formula 2 which did not contain rhubarb and contained the highest level of gum, while the highest TPC value was determined in the biscuit formula 1 which did not contain gum, but contained the highest level of rhubarb. The DPPH scavenging values of the gluten-free biscuits were 42.60% and 57.51%. The addition of rhubarb alone in the formula increased antioxidant activity. However, the addition of rhubarb with gum in the formula decreased antioxidant activity. The aim of this study was to produce biscuits with high nutritional value using functional food components for the consumption of patients with celiac disease. The addition of rhubarb increased the TPC of the biscuits as well as the functional properties of the biscuits by inhibiting free radicals.
ObjectiveSilver nanoparticles (AgNPs) are widely utilized in anti-migratory applications due to their beneficial physicochemical and biological properties. This study aimed to evaluate the in vitro cytotoxic and anti-migratory effects of AgNPs synthesized using the above-ground parts (stems, flowers, and leaves) of Onosma mutabilis (O. mutabilis).SignificanceGreen-synthesized AgNPs derived from O. mutabilis exhibit notable cytotoxic and anti-migratory effects on A549 cells, offering dual-functional potential. Their biocompatibility and capacity for targeted release in acidic tumor microenvironments make them promising candidates for sustainable cancer therapies.MethodsAgNPs were green-synthesized using aqueous plant extracts and characterized by ultraviolet-visible spectroscopy (UV-Vis spectroscopy), X-ray diffraction (XRD), fourier transform infrared (FTIR), and scanning electron microscopy (SEM). Cytotoxicity against A549 cells was assessed via the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay and anti-migratory effects were examined using a scratch assay.ResultsUV-Vis spectroscopy confirmed the formation of AgNPs synthesised from O. mutabilis extracts by showing a characteristic absorption band around 420-480 nm. XRD analysis revealed their crystalline structure, while SEM demonstrated predominantly spherical morphology. MTT assay indicated that the AgNPs, especially those derived from the flower extract, significantly reduced A549 cell viability in a dose- and time-dependent manner, with an IC50 value of 5.28 µg/mL. In addition, wound healing assays confirmed their strong anti-migratory activity.ConclusionThese findings suggest that green-synthesised AgNPs induce cytotoxic and anti-migratory effects, highlighting their potential as therapeutic agents against A549 lung cancer cells.
Background: Although vaccination programs have significantly reduced the incidence of hepatitis B, chronic infection with the hepatitis B virus (HBV) continues to be a major contributor to liver-related morbidity and mortality. Among available therapeutic outcomes, the clearance of hepatitis B surface antigen (HBsAg) is considered the most favorable endpoint. Objectives: This study aims to evaluate genetic variations in the promoter region of the interferon gamma (IFN-γ)-inducible protein-10 (IP-10) gene — an important chemokine involved in inflammatory responses — which may play a role in the loss of HBsAg during chronic HBV infection. Methods: This research was designed as a single-center case-control study. The study included 60 patients with documented HBsAg loss, retrospectively identified from a cohort of 1,950 chronic hepatitis B patients who were followed at the Infectious Diseases and Clinical Microbiology outpatient clinic of Cukurova University Hospital between 2005 and 2022. A control group of 60 patients who remained HBsAg positive was also included. Peripheral blood samples were collected from all participants, and deoxyribonucleic acid (DNA) was extracted to analyze IP-10 gene polymorphisms. The target gene region was amplified using polymerase chain reaction (PCR), followed by Sanger sequencing. Based on data from the Genome-Wide Association Studies (GWAS) database and published literature, three variants located within the IP-10 promoter, exon 1, intron 1, and exon 2 regions were selected for analysis. The resulting sequence data (in .ab1 format) were analyzed using the CLC Genomics Workbench 24 software. Results: Between 2005 and 2022, the rate of HBsAg loss was calculated as 5.33%. The average age at which HBsAg loss occurred was 53.2 ± 11.3 years, and 85% of the individuals experienced this loss after the age of 40. When comparing the case and control groups, no statistically significant differences were found in terms of gender, current age, age at diagnosis, Body Mass Index, alcohol use, or smoking habits (P > 0.05). Three polymorphisms — c.-135C>T (rs56061981), c.85C>T (rs11548618), and c.83T>G — were detected within the promoter and exon 2 regions of the IP-10 gene. Analysis of genotype and allele distributions revealed no significant differences between the two groups for any of these variants (P > 0.05). Conclusions: Our findings suggest that the c.-135C>T, c.85C>T, and c.83T>G polymorphisms within the IP-10 gene region are not associated with HBsAg loss and therefore may not serve as reliable predictive markers.